Flutamide hepatotoxicity

Journal of Urology

Volumn 155, Issue 1, 1996, Pages 209-212

  Wysowski, Diane K ^a   Fourcroy, Jean L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Flutamide; Hepatitis; Liver diseases; Liver failure; Toxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DIETHYLSTILBESTROL; FLUTAMIDE; GLIBENCLAMIDE; GONADORELIN AGONIST;

ADULT; AGED; ALOPECIA; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; DOSE RESPONSE; DRUG FATALITY; DRUG MONITORING; FEMALE; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; HOSPITALIZATION; HUMAN; LIVER FUNCTION TEST; LIVER INJURY; LIVER TOXICITY; MALE; ORAL DRUG ADMINISTRATION; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT OUTCOME;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FLUTAMIDE; HEPATITIS, TOXIC; HIRSUTISM; HOSPITALIZATION; HUMAN; LIVER FUNCTION TESTS; MALE; PROSTATIC NEOPLASMS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0029656166     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66596-0     Document Type: Article

References (27)

1. Crawford, E. D., Eisenberger, M. A., McLeod, D. G., Spaulding, J. T., Benson, R., Dorr, F. A., Blumenstein, B. A., Davis, M. A. and Goodman, P. J.: A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. New Engl. J. Med., 321: 419, 1989.
2. Denis, L. J., Carneiro de Moura, J. L., Bono, A., Sylvester, R., Whelan, P., Newling, D. and DePauw, M.: Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center. Urology, 42: 119, 1993.
3. Wysowski, D. K., Freiman, J. P., Tourtelot, J. B. and Horton, M. L., III: Fatal and nonfatal hepatotoxicity associated with flutamide. Ann. Intern. Med., 118: 860, 1993.
4. National Prescription Audit. Plymouth Meeting, Pennsylvania: IMS America, 1989-1994.
5. Perez Gutthann, S. and Garcia Rodriguez, L. A.: The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs. Epidemiology, 4: 496, 1993.
6. Carson, J. L., Strom, B. L., Duff, A., Gupta, A. and Das, K.: Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease. Arch. Intern. Med., 153: 1331, 1993.
7. Perez Gutthann, S., personal communication.
8. Schering-Plough Research Institute, New Drug Application 18-554, vol. 8, pp. 11-530-649, September 28, 1987.
9. Gomez, J. L., Dupont, A., Cusan, L., Tremblay, M., Suburu, R., Lemay, M. and Labrie, F.: Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Amer. J. Med., 92: 465, 1992.
10. Dourakis, S. P., Alexopoulou, A. A. and Hadziyannis, S. J.: Fulminant hepatitis after flutamide treatment. J. Hepatol., 20: 350, 1994.
11. Martínez Bruna, M. S., Velila Alcubilla, J. P., Abinzano, M., Martínez Velasco, C., García Mauriz, M. E. and Urbieta Echezareta, M.: Hepatoxicidad y flutamida. Ann. Med. Interna, 10: 566, 1993.
12. Wallace, C., Lalor, E. A. and Chik, C. L.: Hepatotoxicity complicating flutamide treatment of hirsutism. Ann. Intern. Med., 119: 1150, 1993.
13. Rosman, A. S., Frissora-Rodeo, C., Marshall, A. T., Reiter, B. P. and Paronetto, F.: Cholestatic hepatitis following flutamide. Dig. Dis. Sci., 38: 1756, 1993.
14. Corkery, J. C., Bihrle, W., III, McCaffrey, J. A., Whitcomb, F. F., Levy, C. and Ellis, R.: Flutamide-related fulminant hepatic failure. J. Clin. Gastroenterol., 13: 364, 1991.
15. Prattichizzo, F. A.: Acute cholestatic hepatitis secondary to flutamide therapy. Amer. J. Med., 96: 392, 1994.
16. Koning, R. P.: Behandeling van hirsutisme. Nederlands Tijdschrift voor Geneeskunde, 138: 1093, 1994.
17. Caballeria, E., Aragó, J. V. and Sanchis, A.: Hepatotoxicidad por flutamida. Med. Clin., 102: 434, 1994.
18. Dankoff, J. S.: Near fatal liver dysfunction secondary to administration of flutamide for prostate cancer. J. Urol., 148: 1914, 1992.
19. Alperine, M., Cohen, L., Cocheton, J. J., Lecomte, I. and Meyniel, D.: Hépatite aiguë due au flutamide. Presse Med., 20: 1459, 1991.
20. Møller, S., Iversen, P. and Franzmann, M. B.: Flutamide-induced liver failure. J. Hepatol., 10: 346, 1990.
21. Coppéré, H., Perraud, Y., Gérard, F., Jouffre, C., David, A., Barthélémy, C. and Audigier, J. C.: Un cas d'hépatite aiguë au flutamide. Gastroenterol. Clin. Biol., 14: 105, 1990.
22. Hart, W. and Stricker, B. H.: Flutamide and hepatitis. Ann. Intern. Med., 110: 943, 1989.
23. Moller, S. and Iversen, P.: Svaer toksisk hepatitis under flutamid-(Eulexin)-behandeling. Ugeskr. Laeger, 151: 173, 1989.
24. Iversen, P., Wolf, H., Hvidt, V., Krarup, T., Rasmussen, F. and the Danish Prostate Cancer Group: Zoladex plus flutamide vs. orchiectomy in the treatment of advanced prostatic cancer. J. Urol., part 2, 141: 348A, abstract 713, 1989.
25. Lund, F. and Rasmussen, F.: Flutamide versus stilboestrol in the management of advanced prostatic cancer. A controlled prospective study. Brit. J. Urol., 61: 140, 1988.
26. Lundgren, R.: Flutamide as a primary treatment for metastatic prostatic cancer. Brit. J. Urol., 59: 156, 1987.
27. Fau, D., Eugene, D., Berson, A., Letteron, P., Fromenty, B., Fisch, C. and Pessayre, D.: Toxicity of the antiandrogen flutamide in isolated rat hepatocytes. J. Pharmacol. Exp. Ther., 269: 954, 1994.